# Presidio Property Trust, Inc.: financial statements, quarterly

SQFT · Nasdaq · CIK 1080657 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sqft.md) · [Financials](/companies/sqft/financials.md) · [Filings](/companies/sqft/filings.md) · [Insiders](/companies/sqft/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sqft/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.5](/filings/0001437749-24-035719.md) | [1.5 d](/filings/0001437749-25-010185.md) | [4.0](/filings/0001437749-25-016828.md) | [3.9](/filings/0001437749-25-026786.md) | [4.0](/filings/0001437749-25-034461.md) | [3.9 d](/filings/0001437749-26-010114.md) | [3.6](/filings/0001437749-26-017340.md) | [3.6](/filings/0001437749-26-027591.md) | [3.5](/filings/0001437749-25-034461.md) | [3.4 d](/filings/0001437749-26-010114.md) | [3.2](/filings/0001437749-26-017340.md) | [3.4](/filings/0001437749-26-027591.md) |
| Operating income | $m | not reported | not reported | [3.2](/filings/0001437749-25-016828.md) | [3.1](/filings/0001437749-25-026786.md) | [3.1](/filings/0001437749-25-034461.md) | [3.2 d](/filings/0001437749-26-010114.md) | [2.5](/filings/0001437749-26-017340.md) | [2.9](/filings/0001437749-26-027591.md) | [2.7](/filings/0001437749-25-034461.md) | [2.6 d](/filings/0001437749-26-010114.md) | [2.2](/filings/0001437749-26-017340.md) | [2.6](/filings/0001437749-26-027591.md) |
| Interest expense | $m | [1.4](/filings/0001437749-24-035719.md) | [1.4 d](/filings/0001437749-24-012230.md) | [1.5](/filings/0001437749-24-016619.md) | [1.5](/filings/0001437749-24-026730.md) | [1.5](/filings/0001437749-24-035719.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001437749-24-035719.md) | [(1.0) d](/filings/0001437749-25-010185.md) | [0.1](/filings/0001437749-25-016828.md) | [0.1](/filings/0001437749-25-026786.md) | [0.0](/filings/0001437749-25-034461.md) | [(0.1) d](/filings/0001437749-26-010114.md) | [(0.0)](/filings/0001437749-26-017340.md) | [0.1](/filings/0001437749-26-027591.md) | [(0.0)](/filings/0001437749-25-034461.md) | [0.4 d](/filings/0001437749-26-010114.md) | [0.0](/filings/0001437749-26-017340.md) | [0.0](/filings/0001437749-26-027591.md) |
| Net income | $m | [21.5](/filings/0001437749-24-035719.md) | [(9.0) d](/filings/0001437749-25-010185.md) | [(5.2)](/filings/0001437749-25-016828.md) | [(11.8)](/filings/0001437749-25-026786.md) | [(6.1)](/filings/0001437749-25-034461.md) | [(2.5) d](/filings/0001437749-26-010114.md) | [2.3](/filings/0001437749-26-017340.md) | [(5.3)](/filings/0001437749-26-027591.md) | [(1.3)](/filings/0001437749-25-034461.md) | [(4.0) d](/filings/0001437749-26-010114.md) | [0.4](/filings/0001437749-26-017340.md) | [(3.8)](/filings/0001437749-26-027591.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [1.77](/filings/0001437749-24-035719.md) | not reported | [(0.47)](/filings/0001437749-25-016828.md) | [(9.97)](/filings/0001437749-25-026786.md) | [(5.33)](/filings/0001437749-25-034461.md) | not reported | [1.31](/filings/0001437749-26-017340.md) | [(5.13)](/filings/0001437749-26-027591.md) | [(1.53)](/filings/0001437749-25-034461.md) | not reported | [(0.10)](/filings/0001437749-26-017340.md) | [(3.33)](/filings/0001437749-26-027591.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [178](/filings/0001437749-23-031953.md) | [176](/filings/0001437749-25-010185.md) | [163](/filings/0001437749-24-016619.md) | [151](/filings/0001437749-24-026730.md) | [146](/filings/0001437749-24-035719.md) | [143](/filings/0001437749-26-010114.md) | [135](/filings/0001437749-25-016828.md) | [128](/filings/0001437749-25-026786.md) | [128](/filings/0001437749-25-034461.md) | [122](/filings/0001437749-26-027591.md) | [111](/filings/0001437749-26-017340.md) | [107](/filings/0001437749-26-027591.md) |
| Total liabilities | $m | [110](/filings/0001437749-23-031953.md) | [115](/filings/0001437749-25-010185.md) | [108](/filings/0001437749-24-016619.md) | [106](/filings/0001437749-24-026730.md) | [108](/filings/0001437749-24-035719.md) | [108](/filings/0001437749-26-010114.md) | [98.9](/filings/0001437749-25-016828.md) | [99.0](/filings/0001437749-25-026786.md) | [98.5](/filings/0001437749-25-034461.md) | [97.4](/filings/0001437749-26-027591.md) | [86.1](/filings/0001437749-26-017340.md) | [85.2](/filings/0001437749-26-027591.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [60.0](/filings/0001437749-23-031953.md) | [51.0](/filings/0001437749-25-010185.md) | [45.4](/filings/0001437749-24-016619.md) | [34.9](/filings/0001437749-24-026730.md) | [29.5](/filings/0001437749-24-035719.md) | [26.5](/filings/0001437749-26-010114.md) | [28.3](/filings/0001437749-25-016828.md) | [21.1](/filings/0001437749-25-026786.md) | [21.1](/filings/0001437749-25-034461.md) | [16.8](/filings/0001437749-26-027591.md) | [17.5](/filings/0001437749-26-017340.md) | [13.9](/filings/0001437749-26-027591.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,247 d](/filings/0001437749-24-035719.md) | [1,806 d](/filings/0001437749-25-010185.md) | [(867)](/filings/0001437749-25-016828.md) | [(434) d](/filings/0001437749-25-026786.md) | [643 d](/filings/0001437749-25-034461.md) | [(69.6) d](/filings/0001437749-26-010114.md) | [(119)](/filings/0001437749-26-017340.md) | [(893) d](/filings/0001437749-26-027591.md) | [632 d](/filings/0001437749-25-034461.md) | [798 d](/filings/0001437749-26-010114.md) | [(957)](/filings/0001437749-26-017340.md) | [982 d](/filings/0001437749-26-027591.md) |
| Dividends paid | $k | [302 d](/filings/0001437749-24-035719.md) | [302 d](/filings/0001437749-25-010185.md) | [0.0](/filings/0001437749-24-016619.md) | [0.0 d](/filings/0001437749-24-026730.md) | [0.0 d](/filings/0001437749-24-035719.md) | [0.0 d](/filings/0001437749-25-010185.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-017340.md) | not reported |
| Share repurchases | $k | [0.0 d](/filings/0001437749-24-035719.md) | [0.0 d](/filings/0001437749-25-010185.md) | not reported | not reported | [89.8 d](/filings/0001437749-24-035719.md) | [43.0 d](/filings/0001437749-25-010185.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2018 (2018-09-30) | Q3 FY2019 (2019-09-30) | Q3 FY2020 (2020-09-30) |
| --- | --- | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.7](/filings/0001080657-19-000009.md) | [9.3](/filings/0001437749-20-022782.md) | [8.9](/filings/0001437749-20-022782.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,434,432 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027591.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.